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abstract Current research work involves preparation of fast dissolving 
tablets of Losartan Potassium by direct compression method using different 
concentrations of Plantago ovata and Lepidium sativum mucilage as natural 
superdisintegrants. A two factor three level (32) factorial design is being 
used to optimize the formulation. Nine formulation batches (A1-A9) were 
prepared by taking two factors as independent variables (X
1
- amount of 
Plantago ovata mucilage and X
2
- amount of Lepidium sativum mucilage) 
were taken with three levels (+1, 0, -1). All the active blends were evaluated 
for precompression parameters (angle of repose, bulk density, carr’s index, 
hausner’s ratio) and formulated tablets were evaluated for post compression 
parameters (hardness, friability, weight variation, wetting time, disintegration 
time, water absorption ratio). In vitro drug release studies were carried out 
using USP II dissolution apparatus for 30 min. The software Design Expert 
(8.0.7.1) was used for generating experimental design, modeling the response 
surface and calculating the statistical evaluation. Tablet parametric tests of 
formulation batches (A1-A9) of FDT were found within prescribed limits. 
DT was observed in the range from 12±2 to 58.7±2.52 sec and WT from 
10.3±1.52 to 49.7±5.13 sec for formulation batches (A1-A9). More than 
87% drug release was observed in all formulation batches (A1-A9) within 
15 minutes. Polynomial mathematical models, generated for various 
response variables using multiple linear regression analysis, were found to be 
statistically significant (P < 0.05). Formulation A7 was selected by the design 
expert software which exhibited DT (22.15sec), WT (17.31sec) and in vitro 
drug release (100%) within 15 minutes.
keywords: Disintegration time, wetting time, factorial design, plantago 
ovata, lepidium sativum







Developing new drug delivery technologies and utilizing them in product development is critical for pharmaceutical industries to survive, regardless of their size. Recent advances in novel drug 
delivery systems (NDDS) aim to enhance safety and efficacy of drug 
molecule by formulating a convenient dosage form for administration 
and to achieve better patient compliance i.e., one, which will rapidly 
disintegrate in the mouth without need of water (fast dissolving tablet). 
Fast dissolving tablets has emerged as alternative oral dosage forms which 
is a major concern in the treatment of hypertension, diabetics and other 
diseases where they offer advantages over older formulation in terms 
of convenience, side-effect profiles, efficacy/ or a fast onset of action 
(Shirsand et al, 2006). The basic approach used in the development of 
FDT is the use of superdisintegrants (synthetic or natural) which lead 
to instantaneous disintegration of tablet after putting on tongue, thereby 
releasing the drug in saliva (Bhowmik et al, 2009). Mucilage and gums 
have been widely used in the pharmaceutical industries as thickeners, 
water retention agents, and emulsion stabilizers, suspending agents, 
binders and film formers. Mucilage of natural origin is preferred over 
synthetic compounds because they are cheaper, nontoxic and nonirritating 
in nature and easily available (Malik et al, 2012; Sharma et al, 2013). 
Lepidium sativum (Family:  Cruciferae) is known as asaliyo and widely 
used as herbal medicine in India. It is widely available in market and has 
very low cost. The seeds contain higher amount of mucilage, dimeric 
imidazole alkaloids lepidine B, C, D, E and F and two new monomeric 
imidazole alkaloids semilepidinoside A and B. Mucilage of Lepidium 
sativum has various characteristic like binding, disintegrating, gelling 
etc (Patel et al, 2007). Ispaghula mucilage consists of epidermis of the 
dried seeds of Plantago ovata (Family: Plantaginaceae). It is mainly used 
as a dietary fibre. Psyllium mucilage absorbs excess water and is also 
reported as superdisintegrants (Shirsand et al, 2009).  Losartan Potassium 
is an angiotensin II receptor antagonist used in the management of 
hypertension with half-life of approximately 1.5-2 h. The bioavailability 
of Losartan Potassium is poor (about 25-35%) which is due to extensive 
first pass metabolism (Avulapati et al, 2011). Present study involves the 
development of fast dissolving tablets of losartan potassium using 32 
factorial design. The effect of amount of independent variables (Plantago 
ovata and Lepidium sativum mucilage) on dependent variables such as 













2. MaTeRiaLS aND MeThODOLOGy
2.1 Materials
Losartan Potassium and Avicel PH-102 (Ontop Pharmaceutical Pvt. Ltd. 
Bangalore, India); Pearlitol 200 D (Signet chemical corporation Pvt. Ltd. 
Mumbai, India); Aspartame (IPZA Pharmaceutical Pvt. Ltd. Patiala, India) 
were obtained as gift samples. Seeds of Plantago ovata and Lepidium sativum 
were purchased from local market. All other chemical used were of analytical 
grade.
2.2 Methods
2.2.1 Extraction of mucilage
Isolation of Mucilage from Plantago ovata seeds: The seeds of Plantago ovata 
were soaked in distilled water for 48 h and then boiled for 1 h for complete 
release of mucilage into water and then filtered by squeezing in a muslin cloth 
to remove marc followed by addition of equal volume of acetone to precipitate 
the mucilage. The mucilage was separated and dried in oven at a temperature 
NMT 60 ± 2oC, powered and sieved (80 #), weighed and stored in desiccator 
until further use (Washi et al, 1985; Baveja et al, 1989; Chakraborthy et al, 
2008).
Isolation of Mucilage from Lepidium sativum seeds : The seeds of Lepidium 
sativum contain the mucilage around the outer layer. The seeds were boiled 
with distilled water for 15 minute and the mass was filtered through buckner 
funnel without filter paper and the retained residues were boiled with distilled 
water for 15 minute and the combined liquid was passed through eight folds 
of muslin cloth. Then the mucilage was precipitated from the filtrate by adding 
ethanol (sufficient to cause precipitation). The precipitated mucilage was dried 
in oven at temperature NMT 45±2oC till it was completely dried. The powder 
was sieved through 80 #, weighed and stored in desiccator until further use 
(Hasegawa et al, 1992).
2.2.2 Preparation of fast dissolving tablets (preliminary batches)
Fast dissolving tablets (F1-F10) of Losartan potassium were prepared using 
direct compression method. All the ingredients were taken in sufficient quantity 
and passed through sieve no. 60. Then all the ingredients were co-grinded in a 
mortar and pestle and lubrication was done using talc and magnesium stearate. 
The two mucilages were used in 1%, 3%, 5%, 7% and 9% individually (i.e. 
F1-F5 using Plantago ovata mucilage and F6-F10 using lepidium sativum 






mucilage). Single punch tablet compression machine was used to produce 
convex faced tablets weighing 140 mg each with a diameter of 8mm. The 
Composition of preliminary batches is given in Table 1.
Table 1. Composition of Preliminary batches (F1-F10)
ingredients F1 F2 F3 F4 F5 F6 F7 F8 F9 F10
Losartan potassium 
(LP)
25 25 25 25 25 25 25 25 25 25






1.4 4.2 7.0 9.8 12.6
Avicel PH-102 75 75 75 75 75 75 75 75 75 75
Mannitol 33.6 30.8 28 25.2 22.4 33.6 30.8 28 25.2 22.4
Aspartame 2 2 2 2 2 2 2 2 2 2
Magnesium stearate 2 2 2 2 2 2 2 2 2 2
Talc 1 1 1 1 1 1 1 1 1 1
*All the ingredients are expressed in mg
2.2.3 Evaluation of preliminary batches (F1-F10)
The preliminary batches were evaluated for precompression parameters (Bulk 
density, Tapped density, Angle of repose, Carr’s index, Hausner’s ratio), post 
compression parameters (friability, hardness, weight variation, disintegration 
time, wetting time, water absorption ratio) and in vitro dissolution studies.
2.2.4 Preparation of final batches using 32 factorial design
A 32 factorial design was constructed using two independent variables X
1 
(amount 
of Plantago ovata mucilage) and X
2
 (amount of Lepidium sativum mucilage) and 
their effect on disintegration time, wetting time and percent cumulative release 
was determined. Each factor was tested at three levels (-1, 0, +1) indicating low, 
medium and high values. The levels were selected on the basis of preliminary 
studies. Design Expert (8.0.7.1) was used for generating experimental design, 
modeling the response surface and for statistical evaluation. 
2.2.5 Evaluation of Final Batches (A1-A9)
2.2.5.1 Precompression Parameters
Angle of Repose: It is an indicative of the flow properties of the powder. Angle 
of repose is determined by the following formula









Tan θ = h/r,
Where h is the height of the cone in cm and r is radius of the cone base in cm.
Bulk Density: Bulk density (D
b
), is defined as the mass of the powder 





Where M is weight of powder in g, V
b 
is bulk volume of powder in cm3 
Tapped Density: It is the ratio of total mass of the powder to the tapped 
volume of the powder. It is expressed in g/cm3 and is given by
D
t
 = M/ V 
t
Where M is weight of powder in g and V
t 
 is the tapped volume of powder in cm3 
Carr’s Index: It indicates powder flow properties. It is expressed in 










 is the tapped density of the powder and D
b
 is the bulk density of the 
powder
Hausner’s Ratio: Hausner’s ratio is an indirect index of ease of powder 
flow. It is calculated by the following formula.






 is the tapped density; D
b
 is the bulk density
2.2.5.2 Post compression Parameters 
Diameter and Thickness: A calibrated vernier caliper was used to evaluate 
diameter and thickness of the tablets. Tablet thickness should be controlled 
within a ±5% variation of a standard value.
Hardness: Hardness was measured using Monsanto tablet hardness tester. 
A tablet of hardness of about 3-5 kg/cm2 is considered adequate for mechanical 
stability. 
Weight variation test: The weight variation test is carried out in order to 
ensure uniformity in the weight of tablets in a batch. 
Friability test: Roche friabilator was employed to evaluate the friability of 
the tablets. Percent loss in weight was calculated by following formula:
















 is the Weight of tablet before and after test
Disintegration Test: The disintegration time for all formulations was 
evaluated using USP tablet disintegration test apparatus as specified in 
USP.
Wetting Time: To determine the wetting time, five circular tissue papers 
of 10 cm diameter were placed in a petridish containing 0.2% w/v solution of 
eosin (3ml). A tablet was carefully placed on the surface of the tissue paper. 
The time required for developing reddish color on the upper surface of the 
tablets was noted as the wetting time or the time for complete wetting of the 
tablet was measured in seconds. 
Water Absorption Ratio: A small piece of tissue paper folded twice was 
placed in a small petridish containing 6ml of water. A tablet was put on the 
paper and the time required for complete wetting was measured. The wetted 
tablet was then reweighed. Water absorption ratio, R was determined by using 
following formula.











 is the weight of tablet before and after water absorption respectively.
2.2.5.3 Fourier Transform Infrared Spectroscopy (FTIR)
IR spectra of pure drug, both mucilage powders and formulation batch were 
determined using FTIR spectrophotometer (Perkin Elmer Spectrum 400) by 
KBr pellet method. About 10 mg of sample was mixed with dried potassium 
bromide of equal weight. The mixture was properly grinded using pestle and 
mortar. Pellets were formed by compressing the mixture by using hydraulic 
press. Transparent pellets formed in this way are scanned. The spectra are 
scanned over a frequency range of 4000-400cm- 1.
2.2.5.4 In vitro Dissolution Test 
All the formulations (A1-A9) were subjected to in vitro drug release studies 
using eight stage dissolution test apparatus (DISSO 2000, Lab India) using 
900ml of dissolution medium (pH 6.8 phosphate buffer) maintained at 
37±10oC for 60 minutes. The tablets were kept in the cylindrical basket and 
rotated at 50 rpm. Aliquots were withdrawn at specified time intervals (5, 10, 
15, 30, 45 and 60 minutes) and absorbance of the samples was measured using 
UV spectrophotometer (Systronics, India) at
 
210 nm. Cumulative percent 
drug release was then calculated. The dissolution studies were performed in 
triplicate and expressed as mean± SD.









3. ReSULTS aND DiSCUSSiON
3.1 evaluation of Preliminary Batches (F1-F10) 
3.1.1 Precompression Parameters
The results of bulk density and tapped density were ranged from (0.464 to 0.543 
g/cc) and (0.522 to 0.627 g/cc) respectively. The results of angle of repose 
(11.3° to 29.7°) indicate good flow properties which were further supported 
by Carr’s index values (11.14% to 13.33%) and Hausner’s ratio data (1.12 to 
1.19). The results of precompression parameters are given in Table 2.
3.1.2 Fourier Transform Infrared Spectroscopy (FTIR)
FTIR of pure drug, Plantago ovata and Lepidium sativum mucilage and 
formulation batch (F1) are shown in Figures 1, 2,3 and  4 respectively. The 
presence of characteristics peaks of drug OH (3198 cm-1), CH Stretching 
Aromatic (3034 cm-1), CH Stretching Aliphatic (2956 cm-1) C=0 (1642 
cm-1), C=C (1578 cm-1), C-O-C Ether Linkage (1189 cm-1) in IR spectrum of 
formulation (Figure 4), indicated no interaction of drug with the polymer and 
other excipients.
3.1.3 Postcompression Parameters
The prepared tablets from all formulations possessed good mechanical strength 
with sufficient hardness in the range of (2.6 ±0.2 kg/cm2 to 3.07 ±0.06 kg/cm2). 
Friability values below 1% indicated good mechanical resistance of tablets. All 
Table 2. Results of Pre-compression parameters of preliminary batches 
 (F1-F10)








0.573 0.522 0.595 0.557 0.531 0.599 0.609 0.585 0.627 0.599
Angle of 
repose (°) 27.14 28.88 29.7 25.9 27.66 13.99 11.30 12.49 13.33 11.87
Carr’s 
index (%) 12.9 11.14 12.43 11.75 11.86 11.9 13.32 12.49 13.33 13.02
Hausner’s 
ratio 1.14 1.12 1.14 1.13 1.13 1.19 1.15 1.13 1.15 1.14






tablet batches passed weight variation test as % weight variation was within 
pharmacopoeial limits. All the batches showed wetting time in the range of 
(10.33±1.52 sec to 23±1.73 sec). Disintegration time (DT) value of less than 1 
min was observed in all formulations and it varied between (14.7±2.51 sec  to 
Figure 1. FTIR spectra of pure drug (Losartan Potassium)
Figure 2. FTIR spectra of Plantago ovata mucilage powder
Figure 3. FTIR spectra of Lepidium Sativum mucilage powder









53.7±2.89 sec). All the formulation batches showed water absorption ratio in 
the range of (110.3±1.52 % to131.7±2.08%). Disintegration time was decreased 
with increasing amount of superdisintegrant Plantago ovata mucilage (batch 
F1 to F4) and (batch F6 to F9). Further increase in concentration of mucilage 
(9% Plantago ovata in batch F5 and 9% Lepidium sativum in batch F10) leads 
to increase in DT. This may be due to formation of viscous plugs at higher 
concentration of the mucilage. The same was observed in batches containing 
Lepidium Sativum mucilage (batch F6- F10). The results of post compression 
parameters are given in Table 3.
Figure 4. FTIR spectra of formulation batch


















F1 Pass 2.6±0.2 22±6 112.3±4.93 0.68±0.02 53.7 ±2.89
F2 Pass 3.07±0.06 18±2 120.3±3.51 0.77±0.02 40±4
F3 Pass 2.8±0.1 14.33 ±2.08 128±2 0.71±0.01 19.7 ±3.78
F4 Pass 3.03 ±0.15 12.67 ±1.15 130±3.5 0.73±0.03 15.7±2.1
F5 Pass 2.73±0.06 15.67±2.08 131.7±2.08 0.80±0.03 18.7±2.52
F6 Pass 2.93 ±0.06 23 ±1.73 110.3±1.52 0.66 ±0.04 53±2.64
F7 Pass 2.98 ±0.006 16 ±2.64 119.3±2.52 0.79±0.02 38 ±5.29
F8 Pass 2.93±0.06 11.7±0.577 126.3±1.52 0.74±0.06 18.7±3.05
F9 Pass 2.76 ±0.06 10.33 ±1.52 127.3±2.89 0.71±0.01 14.7 ±2.51
F10 Pass 3.07±0.06 14.67±4.04 128.7±3.51 0.83±0.03 17±2.64






3.1.4 In vitro dissolution studies
More than 83% drug release was observed in all formulation batches (F1-F10) 
with maximum (100%) in batch F3 within 15 min. In vitro dissolution of all 
formulation batches (F1-F10) is given in Figure 5.
Figure 5. In vitro drug release of Preliminary batches (F1-F10)
3.2 evaluation of Final Batches (a1-a9)
3.2.1 Precompression Parameters
The results of bulk density and tapped density were ranged from (0.458 g/ml 
to 0.515 g/ml) and (0.548 g/ml to 0.605 g/ml) respectively. The results of angle 
of repose (20.30° to 25.64°) indicate good flow properties which were further 
supported by Carr’s index values (11.7 % to 17.6 %) and Hausner’s ratio data 
(1.13 to 1.21). The results of pre compression parameters are given in Table 4.
Table 4. Results of pre compression parameters of final batches (A1-A9)
Batch code → 
Parameter↓ a1 a2 a3 a4 a5 a6 a7 a8 a9
Bulk density 
(g/ml) 0.481 0.484 0.458 0.514 0.515 0.504 0.482 0.484 0.514
Tapped density 
(g/ml) 0.584 0.548 0.550 0.587 0.589 0.590 0.570 0.556 0.605
Angle of 
repose (°) 20.30 24.70 21.30 22.78 22.78 21.30 22.29 23.74 25.64
Carr’ s index 
(%) 17.6 11.7 16.6 12.5 12.5 14.6 15.2 12.9 15
Hausner’s 
ratio 1.21 1.13 1.20 1.14 1.14 1.17 1.18 1.14 1.17










The prepared tablets from all formulations possessed good mechanical strength 
with sufficient hardness in the range of (2.67±0.21 kg/cm2 to 3.23±0.252 kg/
cm2). Friability values below 1% are good indication of good mechanical 
resistance of tablets. All tablet batches passed weight variation test as % 
weight variation was within pharmacopoeia limits of (±7.5%) of weight. All 
the batches showed wetting time in the range of (10.3±1.52 sec to 49.7±5.13 
sec). All the formulation batches showed disintegration time (DT) value of less 
than 1 minute varied between (12±2 sec to 58.7 ±2.52 sec). All the formulation 
batches Water absorption ratio of more than 100% indicated enhanced swelling 
characteristics due to presence of mucilage (Table 5).











A1 Pass 2.73±0.05 49.7±5.13 127.3±2.08 0.53±0.15 58.7±2.52
A2 Pass 2.97±0.153 39±1 131.7±3.05 0.78±0.06 50±2
A3 Pass 2.67±0.21 35.7±3.51 133.3±2.08 0.8±0.05 46.7±3.21
A4 Pass 3.23±0.252 33±4.36 136±2.64 0.85±0.05 40±2
A5 Pass 2.73±0.208 30.3±3.21 137.7±1.53 0.91±0.01 33.7±4.04
A6 Pass 2.93±0.06 23.7±1.52 138±3.60 0.50±0.09 26±3.46
A7 Pass 3.07±0.006 17±2.64 140±3.45 0.44±0.04 21.3±1.15
A8 Pass 2.8±0.264 15±1.73 141±2.64 0.65±0.05 17±1
A9 Pass 3±0.1 10.3±1.52 145.7±2.08 0.86±0.05 12±2
3.2.3 In vitro dissolution studies
More than 87% drug release was observed in all formulation batches (A1-A9) 
with maximum release (100%) in batches A4 and A7 within 15 min. In vitro 
dissolution of all formulation batches (A1-A9) is shown in Figure 6.
3.3 experimental Design
To optimize the ratio of mucilage in FDT that can lead to rapid disintegration 
and enhanced dissolution of drug, 9 formulations were prepared according to 
32 factorial design (Table 6). The design provided an empirical second order 
polynomial model. Regression polynomials for the individual dependent 






variables (DT, WT and T
85%
) were calculated and applied to approximate the 
surface responses and contour plots. The general model equation was generated 















































) represent the average result of 
changing one factor at a time from its low to high value. The interaction term 
Figure 6. In vitro drug release profile of Final batches (A1-A9)









A1 -1 -1 58.7±2.52 49.7±5.13 32.2± 2.85
A2 -1 0 50±2 39±1 26.3± 1.13
A3 -1 1 46.7±33.21 35.7±3.51 25.3± 1.09
A4 0 -1 40±2 33±4.36 20.1± 3.1
A5 0 0 33.7±4.04 30.3±3.21 19± 0.45
A6 0 1 26±3.46 23.7±1.52 14.4± 0.67
A7 1 -1 21.3±1.15 17±2.64 12± 1.85
A8 1 0 17±1 15±1.73 10.4± 2.01
A9 1 1 12±2 10.3±1.52 9.4± 0.78
*Translation of coded levels in actual units
Coded level   -1  0  +1
X
1 
: Plantago Ovata (mg)  1.4(1%)  7(5%)  11.2(8%)
X
 2
: Lepidium Sativum (mg)  1.4(1%)  7(5%)  11.2(8%)













) shows changes in the response when two factors are simultaneously 




2 are included to investigate non 
linearity. 
The polynomial equation for DT, WT and T
85%
 was generated by multiple 
linear regression to quantitatively explain the effect of both the mucilage on 
these responses. Various equations are as follows:









































The results of multiple linear regression analysis and ANOVA are represented 
in Table 7. 
Table 7. Summary of results of Regression Analysis and ANOVA for 
measured response
ReSPONSe b0 b1 b2 b12 b11 b22
DT
Full Model 32.87 -17.52 -5.88 0.68 1.05 0.55
P value 0.0009 0.0001 0.0033 0.4789 0.4403 0.6738
Regression DF SS MS F R2
Full Model 5 2053.32 410.86 146.59 0.9891
WT
Full Model 28.91 -13.68 -5.00 1.83 -1.22 0.13
P value 0.0034 0.0005 0.0100 0.1803 0.4723 0.9341
Regression DF SS MS F R2
Full Model 5 1289.72 257.94 58.59 0.973
T-85%
Full Model 17.61 -8.67 -2.53 1.08 1.43 0.33
P value 0.0046 0.0007 0.0228 0.2311 0.2528 0.7642
Regression DF SS MS F R2
Full Model 5 498.13 99.63 48.35 0.9673
3.3.1 Disintegration time (DT)
The response surface plot demonstrated the effect of amount of Plantago 
ovata mucilage and Lepidium sativum mucilage on disintegration time (DT). 
The polynomial equation indicated that disintegration time was decreased 






from 58.7±2.52 sec to 46.7±33.21 sec and from 21.3±1.15 sec to 12±2 sec 
at low and high level of plantago ovata respectively, as the concentration 
of the lepidium sativum was increased. And the DT value decreased from 
58.7±2.52 sec to21.3±1.15 sec and from 46.7±33.21 sec to12±2 sec at low 
and high levels of Lepidium sativum respectively, as the concentration of 
Plantago ovata was increased. Though both the natural polymers resulted 
in decreasing the disintegration time of the tablets with their increased 
amount but increased concentration of Plantago ovata mucilage has more 
significant effect on DT as compared to that observed with increased amount 
of Lepidium sativum mucilage. Figure 7a showed the response surface plot 
for the effect of concentration of Plantago ovata and Lepidium sativum 
mucilage on DT.
3.3.2 Wetting time (WT)
The response surface plot demonstrated the effect of amount of Plantago 
ovata mucilage and Lepidium sativum mucilage on wetting time (WT). The 
polynomial equation indicated that wetting time was decreased from 49.7±5.13 
sec to 35.7±3.51 sec and from 17±2.64 sec to 10.3±1.52 sec  at low and high 
level of plantago ovata respectively, as the concentration of the lepidium 
sativum was increased. And the WT value decreased from 49.7±5.13 sec to 
17±2.64 sec and from 35.7±3.51 sec to 10.3±1.52 sec at low and high levels 
of Lepidium sativum respectively, as the concentration of Plantago ovata was 
increased. Though both the natural polymers resulted in decreasing the wetting 
time of the tablets with their increased amount but increased concentration of 
Plantago ovata mucilage has more significant effect on WT as compared to 
that observed with increased amount of Lepidium sativum mucilage. Figure 7b 
showed the response surface plot for the effect of concentration of mucilage of 
Plantago ovata and Lepidium sativum on wetting time.
3.3.3 T85%
The response surface plot demonstrated the effect of amount of Plantago ovata 
mucilage and Lepidium sativum mucilage on T
85%





was decreased at both low and high levels of Plantago 
ovata (32.2 ± 2.85 min to 25.3± 1.09 min) and (12 ± 1.85 min to 9.4 ± 0.78 min) 
respectively with increasing concentration of Lepidium sativum. The decrease 
was more significant at low and high levels of Lepidium sativum (32.2± 2.85 
min to 12 ±1.85 min) and (25.3 ± 1.09 min to 9.4 ± 0.78 min) respectively with 
increasing concentration of Plantago ovata. Figure 7c showed the response 














A numerical optimization technique using the desirability approach was 
employed to develop a new formulation with the desired responses. Figure 
8 shows the overlay plot indicating the optimum composition and predicted 
responses. Upon the evaluation of the research, the formulation composition 
with plantago ovata concentration and the amount of lepidium sativum was 
fulfilled maximum requirements of an optimum formulation, desirability 
0.983 because of least disintegration time, wetting time and better regulation 
of release rate. The optimized formulation was formulated and evaluated 
for various dependent variables. The response variables were calculated and 
compared to the corresponding predicted values. The prediction error for the 




Figure 7. Response surface plots for (a) DT; (b) WT and (C) T
85%






Figure 8. Overlay plot indicating optimized composition
4. CONCLUSiON
Natural polymers also exhibited great potential in formulation of modified 
drug delivery systems. Fast disintegrating tablets of losartan potassium can be 
prepared using natural mucilage as superdisintegrant. Natural mucilage may 
act by enhanced wetting and swelling of tablets which further leads to better 
disintegration and dissolution characteristics of tablet. A statistical approach 
can reduce the number of experimental runs and provide several formulation 
options with desired disintegration characteristics. It was revealed that several 
combinations of Plantago ovata mucilage and Lepidium sativum mucilage can 
produce tablets of DT less than 1 min and less than 30 min T
85%.
 Plantago 
ovata mucilage has a more significant effect on disintegration and wetting 
characteristics than Lepidium sativum mucilage.
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